Leptin Signaling and Genetic Polymorphisms in Metabolic Health

Summary

Leptin, an adipocyte-derived hormone, orchestrates energy balance by acting on the hypothalamus to suppress appetite and stimulate energy expenditure. Binding to its cognate receptor (LEPR) activates the JAK/STAT signalling cascade, with downstream effects on glucose homeostasis, lipid metabolism and inflammatory pathways. Genetic variations in the LEP and LEPR genes, notably single nucleotide polymorphisms (SNPs), modulate leptin production, receptor function and signal transduction efficiency. Such polymorphisms contribute to inter-individual differences in susceptibility to obesity, insulin resistance, type 2 diabetes and metabolic syndrome. Beyond energy regulation, leptin signalling influences cardiovascular risk factors and hepatic lipid handling, linking adiposity to systemic metabolic health. Recent advances have elucidated how common variants in LEPR (for example, rs1137101) alter receptor binding affinity and circulating leptin levels, while promoter-region SNPs in LEP (such as G2548A) affect gene transcription. These findings underscore the potential for genotype-guided interventions—ranging from metreleptin therapy to targeted lifestyle modifications—and highlight leptin signalling as a nexus for personalised strategies against metabolic disease.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Leptin Signaling and Genetic Polymorphisms in Metabolic Health publication trend

The graph below shows the total number of articles in leptin signaling and genetic polymorphisms in metabolic health across all publications each year (not limited to Nature Index journals).

Technical terms

Leptin: Adipocyte-derived hormone that regulates appetite and energy expenditure.

Leptin receptor (LEPR): Cell-surface receptor that mediates leptin signalling via JAK/STAT pathways.

Single nucleotide polymorphism (SNP): A DNA sequence variation at a single nucleotide position among individuals.

Metabolic syndrome: A cluster of conditions—dyslipidaemia, hypertension, central obesity and hyperglycaemia—that increase cardiovascular and diabetes risk.

JAK/STAT pathway: Intracellular cascade triggered by receptor activation, leading to gene transcription changes in response to hormones and cytokines.

References

  1. Genetic predisposition of LEPR (rs1137101) gene polymorphism related to type 2 diabetes mellitus – a meta-analysis. Annals of Medicine (2023).
  2. LEP (G2548A-G19A) and ADIPOQ (T45G-G276T) gene polymorphisms are associated with markers for metabolic syndrome. Diabetology & Metabolic Syndrome (2023).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.